Isonics Corporation (ISON) Fund Overview
Educational signal · not a buy or sell recommendation · How to read this
DELISTED
What happened to Isonics Corporation (ISON) stock?
Isonics Corporation (ISON) no longer trades on public markets. The figures below are historical and are not a current quote.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Isonics Corporation (ISON). Isonics Corporation operates in the Homeland Security and Defense, Semiconductor, and Life Sciences sectors. The company provides security services, wafer thinning, and isotopes for healthcare, focusing on protecting assets and resources. Sector: Industrials.
Last analyzed: Mar 15, 2026Analyst Coverage for ISON: ISON does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates ISON against Industrials peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
Isonics Corporation (ISON) Industrial Operations Profile
Isonics Corporation serves the Homeland Security, Semiconductor, and Life Sciences industries, offering security services, wafer reclamation, and isotopes. The company focuses on developing solutions for asset protection, providing high-quality wafer services, and supplying isotopes for cancer imaging and treatment, positioning itself as a diversified industrial player.
What Is the Investment Thesis for ISON?
Isonics Corporation operates in diverse sectors, including Homeland Security, Semiconductor, and Life Sciences. Key value drivers include the growing demand for security services, the increasing need for wafer reclamation in the semiconductor industry, and the expanding use of isotopes in healthcare. Growth catalysts involve strategic partnerships and expansion of service offerings within each division. Potential risks include market volatility, competition, and regulatory changes affecting the security, semiconductor, and healthcare industries. Investors should monitor the company's ability to innovate, secure contracts, and maintain regulatory compliance to assess its long-term growth potential.
Based on FMP financials and quantitative analysis
ISON Key Highlights
Operates in three divisions: Homeland Security and Defense, Semiconductor, and Life Sciences.
- Offers security services for businesses and institutions in healthcare, education, retail, manufacturing, banking, and art industries.
- Specializes in high-quality wafer reclaim, test wafer production, wafer thinning, and custom wafer services with a focus on the 300mm market.
- Markets and sells isotopes to the healthcare industry for the imaging and treatment of cancer.
- Founded in 1992 and based in Golden, Colorado.
Who Are ISON's Competitors?
ISON is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| CTAS Cintas Corporation | $202.72 | +2.16% | $81.1B | 915-pillar |
| TRI Thomson Reuters Corporation | $96.84 | +1.18% | $42.3B | 795-pillar |
| CPRT Copart, Inc. | $30.86 | +0.34% | $28.6B | 885-pillar |
| GPN Global Payments Inc. | $88.55 | +1.76% | $22.0B | 445-pillar |
| RBA RB Global, Inc. | $83.48 | +3.65% | $15.6B | 615-pillar |
| ARMK Aramark | $58.52 | +3.10% | $15.4B | 605-pillar |
| ULS UL Solutions Inc. | $71.10 | -2.46% | $14.3B | 815-pillar |
| BIPI BIP Bermuda Holdings I Ltd. | $16.28 | +0.45% | $12.9B | 915-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ISON's Key Strengths?
Diversified business model across multiple sectors.
- Expertise in security services, wafer processing, and isotope technology.
- Focus on high-quality wafer reclaim and custom wafer services.
- Established presence in the Homeland Security, Semiconductor, and Life Sciences markets.
What Are ISON's Weaknesses?
Small market capitalization.
- Limited financial resources compared to larger competitors.
- Dependence on specific contracts and projects for revenue generation.
- Potential vulnerability to market volatility and economic downturns.
What Could Drive ISON Stock Higher?
Expansion of security service offerings to address growing demand for asset protection.
- Development of new isotope products for healthcare applications.
- Strategic partnerships to enhance capabilities and market reach.
- Increasing wafer reclamation services in the semiconductor industry.
- Focus on high-quality wafer reclaim and custom wafer services for the 300mm market.
What Are the Key Risks for ISON?
Competition from larger and more established companies in the security, semiconductor, and healthcare sectors.
- Regulatory changes affecting the security, semiconductor, and healthcare industries.
- Economic downturns impacting demand for security services and semiconductor products.
- Technological advancements rendering existing products and services obsolete.
- Limited financial resources compared to larger competitors.
What Are the Growth Opportunities for ISON?
- Growth opportunity 1: Expanding Homeland Security Services: The increasing demand for security solutions in various sectors, including healthcare and education, presents a significant growth opportunity for Isonics. By developing advanced security technologies and expanding its service offerings, Isonics can capitalize on the growing market for asset protection and risk management. This expansion could lead to increased revenue and market share in the security services industry.
- Growth opportunity 2: Semiconductor Wafer Reclamation: The semiconductor industry's focus on cost reduction and environmental sustainability drives the demand for wafer reclamation services. Isonics can leverage its expertise in wafer thinning and custom wafer services to expand its market share in the 300mm wafer market. This growth opportunity involves investing in advanced equipment and technologies to enhance wafer reclamation capabilities.
- Growth opportunity 3: Life Sciences Isotope Sales: The increasing use of isotopes in cancer imaging and treatment presents a growth opportunity for Isonics in the Life Sciences sector. By expanding its isotope product line and distribution network, Isonics can increase its sales to healthcare providers and research institutions. This growth opportunity requires regulatory compliance and strategic partnerships with healthcare organizations.
- Growth opportunity 4: Strategic Partnerships: Forming strategic alliances with technology providers and industry leaders can enhance Isonics' capabilities and market reach. Collaborations with security technology companies, semiconductor manufacturers, and healthcare organizations can drive innovation and expand the company's service offerings. These partnerships can lead to new revenue streams and competitive advantages.
- Growth opportunity 5: Geographic Expansion: Expanding its operations to new geographic markets can drive growth for Isonics. By targeting regions with high demand for security services, semiconductor manufacturing, and healthcare solutions, Isonics can increase its customer base and revenue. This expansion requires market research, regulatory compliance, and strategic investments in infrastructure and personnel.
What Are ISON's Competitive Advantages?
- Established expertise in security services, wafer processing, and isotope technology.
- Diversified business model across Homeland Security, Semiconductor, and Life Sciences sectors.
- Focus on high-quality wafer reclaim and custom wafer services for the 300mm market.
What Does ISON Do?
Founded in 1992 and based in Golden, Colorado, Isonics Corporation (formerly A&R Materials, Inc.) operates across three divisions: Homeland Security and Defense, Semiconductor, and Life Sciences. The Homeland Security and Defense division develops solutions to protect and secure assets for clients, offering security services to businesses and institutions in healthcare, education, retail, manufacturing, banking, and art industries. The Semiconductor division specializes in wafer reclaim, test wafer production, wafer thinning, and custom wafer services, focusing on the 300mm market. The Life Sciences division markets and sells isotopes to the healthcare industry for cancer imaging and treatment. Isonics aims to provide comprehensive solutions across these sectors, leveraging its expertise in security, semiconductor services, and isotope technology. The company's evolution reflects a diversification strategy to address various industrial and healthcare needs.
What Products and Services Does ISON Offer?
- Offers homeland security products and services to protect assets and resources.
- Provides security services for businesses and institutions in various industries.
- Specializes in high-quality wafer reclaim and test wafer production.
- Offers wafer thinning and custom wafer services for the semiconductor industry.
- Markets and sells isotopes to the healthcare industry for cancer imaging and treatment.
- Focuses on the 300mm wafer market within the semiconductor division.
How Does ISON Make Money?
- Generates revenue through security service contracts with businesses and institutions.
- Earns income from wafer reclaim, thinning, and custom services provided to semiconductor manufacturers.
- Sells isotopes to healthcare providers and research institutions for medical applications.
What Industry Does ISON Operate In?
Isonics Corporation operates within the Specialty Business Services industry, serving the Homeland Security, Semiconductor, and Life Sciences sectors. The security services market is driven by increasing threats and the need for asset protection. The semiconductor industry relies on wafer reclamation to reduce costs and environmental impact. The healthcare sector utilizes isotopes for medical imaging and treatment. Isonics competes with companies offering similar services and products in each sector, requiring continuous innovation and strategic partnerships to maintain a competitive edge.
Who Are ISON's Key Customers?
- Businesses and institutions in healthcare, education, retail, manufacturing, banking, and art industries.
- Semiconductor manufacturers requiring wafer reclaim and custom wafer services.
- Healthcare providers and research institutions using isotopes for cancer imaging and treatment.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price 5 days old
- ● No filing on record
- ● No analyst coverage
- ● This is a fund, not an operating company
MoonshotScore History
Recorded daily since 2026-08-23 · 4 snapshots
| 2026-08-23 | 38 |
| 2026-08-24 | 38 |
| 2026-08-25 | 38 |
| 2026-08-26 | 38 |
What changed?
The score has stayed at 38.
Over the same 3 days the stock moved +0.0%.
Insider Activity
The most recent 11 insider filings for Isonics Corporation break down as 8 sales and 3 purchases. On net that is roughly 2.8M shares acquired (about $336K) — insiders putting money in tends to read as conviction.
Key Financial Metrics
Return on assets is -92.2%, showing how much profit it generates from its asset base. A current ratio of 0.23 means current liabilities exceed short-term assets, a liquidity point worth watching.
Company Profile
Isonics Corporation operates in the Specialty Business Services industry within the Industrials sector. It is headquartered in Golden, US. The company is led by CEO Christopher Toffales. ISON has traded publicly since 2000.
ISON Financials
Bull Case vs Bear Case
Bull Case
- Diversified business model across multiple sectors.
- Expertise in security services, wafer processing, and isotope technology.
- Focus on high-quality wafer reclaim and custom wafer services.
- Established presence in the Homeland Security, Semiconductor, and Life Sciences markets.
Bear Case
- Small market capitalization.
- Limited financial resources compared to larger competitors.
- Dependence on specific contracts and projects for revenue generation.
- Potential vulnerability to market volatility and economic downturns.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
ISON Latest News
No recent news available for ISON.
Leadership: Christopher Toffales
CEO
Christopher Toffales serves as the CEO of Isonics Corporation, managing a team of 384 employees. His leadership is crucial in guiding Isonics across its Homeland Security and Defense, Semiconductor, and Life Sciences divisions, focusing on strategic growth and operational efficiency.
Track Record: Due to limited information on Christopher Toffales' specific achievements and strategic decisions at Isonics, a comprehensive track record cannot be established. Assessing his impact on key company milestones requires further data on his leadership during specific periods and projects.
ISON OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Isonics Corporation may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more difficult for investors to assess their financial health and operational performance. Unlike NYSE or NASDAQ listings, OTC Other stocks often lack stringent listing requirements, resulting in increased risk for investors.
- OTC Tier: OTC Other
- Limited financial disclosure and transparency.
- Lower trading volume and liquidity.
- Wider bid-ask spreads.
- Potential for price manipulation and fraud.
- Higher risk of delisting or suspension of trading.
- Verify the availability and accuracy of financial statements.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Review the company's legal and regulatory compliance.
- Monitor trading volume and price volatility.
- Understand the risks associated with OTC investing.
- Consult with a financial advisor before investing.
- Established business operations in multiple sectors.
- Long operating history since 1992.
- Presence in the Homeland Security, Semiconductor, and Life Sciences markets.
- Focus on high-quality wafer reclaim and custom wafer services.
Isonics Corporation Industrials Stock: Key Questions Answered
What happened to Isonics Corporation (ISON) stock?
Isonics Corporation (ISON) no longer trades on public markets. The figures below are historical and are not a current quote.
Can I still buy ISON shares?
No. ISON stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for ISON elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before ISON stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Isonics Corporation. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does Isonics Corporation do?
Isonics Corporation operates across three divisions: Homeland Security and Defense, Semiconductor, and Life Sciences. The company offers security services to businesses and institutions, specializing in high-quality wafer reclaim, test wafer production, wafer thinning, and custom wafer services for the semiconductor industry.
What do analysts say about ISON stock?
Investors should monitor for updates on analyst ratings, price targets, and financial forecasts. Key valuation metrics to consider include revenue growth, gross margin, and earnings per share.
What are the main risks for ISON?
Isonics Corporation faces several risks, including competition from larger and more established companies in the security, semiconductor, and healthcare sectors.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Limited information available on CEO track record and analyst coverage.
- OTC market investments carry higher risks due to lower liquidity and disclosure requirements.